GLP-1 receptor agonists for obesity treatment

Clinical MedicineUpdated Oct 5, 2026Version v1

Evidence

Public papers linked to this topic and used as evidence for gaps, timelines, and knowledge views.

359 papers

Showing 325-336 of total 359 evidence records.

Open a paper to inspect abstract, source links, and topic context.

2022CrossrefDirectly related27 citations

Efficacy and safety of high‐dose glucagon‐like peptide‐1, glucagon‐like peptide‐1/glucose‐dependent insulinotropic peptide, and glucagon‐like peptide‐1/glucagon receptor agonists in type 2 diabetes

Christophe E. M. De Block; Eveline Dirinck; Ann Verhaegen; Luc F. Van Gaal

May 1, 2022Diabetes, Obesity and Metabolism

2022Semantic ScholarDirectly related126 citations

The Role of Glp-1 Receptor Agonists in Insulin Resistance with Concomitant Obesity Treatment in Polycystic Ovary Syndrome

Krzysztof Bednarz; Karolina Kowalczyk; Marlena Cwynar; Dominika Czapla; Wiktor Czarkowski; Dominika Kmita; Artur Nowak; P. Madej

Apr 1, 2022International Journal of Molecular Sciences6 influential

2022CrossrefDirectly related145 citations

Brain GLP‐1 and the regulation of food intake: GLP‐1 action in the brain and its implications for GLP‐1 receptor agonists in obesity treatment

Stefan Trapp; Daniel I. Brierley

Feb 1, 2022British Journal of Pharmacology

2021OpenAlexDirectly related456 citations

GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects

Xin Zhao; Minghe Wang; Zhitong Wen; Zhihong Lu; Lijuan Cui; Chao Fu; Huan Xue; Yunfeng Liu; Yi Zhang

Aug 23, 2021Frontiers in Endocrinology

2021OpenAlexDirectly related2,036 citations

Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes

Juan P. Frías; Melanie J. Davies; Julio Rosenstock; Federico C. Pérez Manghi; Laura Fernández Landó; Brandon K. Bergman; Bing Liu; Xuewei Cui; Katelyn Brown

Jun 25, 2021New England Journal of Medicine

2021CrossrefDirectly related0 citations

Once weekly semaglutide for treatment of obesity

Nasser Mikhail

Apr 23, 2021Journal of Clinical and Laboratory Research

2021OpenAlexSupporting evidence5,058 citations

Once-Weekly Semaglutide in Adults with Overweight or Obesity

John Wilding; Rachel L. Batterham; Salvatore Calanna; Melanie J. Davies; Luc F. Van Gaal; Ildiko Lingvay; Barbara McGowan; Julio Rosenstock; Marie Thi Dao Tran; Thomas A. Wadden; Sean Wharton; Koutaro Yokote; Niels Zeuthen; Robert F. Kushner

Feb 10, 2021New England Journal of Medicine

2020OpenAlexDirectly related2,009 citations

A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis

Philip N. Newsome; Kristine Buchholtz; Kenneth Cusi; Martin Linder; Takeshi Okanoue; Vlad Ratziu; Arun J. Sanyal; Anne‐Sophie Sejling; Stephen A. Harrison

Nov 13, 2020New England Journal of Medicine

2020OpenAlexDirectly related1,622 citations

GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art

Michael A. Nauck; Daniel R. Quast; Jakob Wefers; Juris J. Meier

Oct 14, 2020Molecular Metabolism

2020OpenAlexSupporting evidence540 citations

Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist

Francis S. Willard; Jonathan D. Douros; M Gabe; Aaron D. Showalter; David B. Wainscott; Todd M. Suter; Megan E. Capozzi; Wijnand J. C. van der Velden; Cynthia Stutsman; Guemalli R. Cardona; Shweta Urva; Paul J. Emmerson; Jens J. Holst; David A. D’Alessio; Matthew P. Coghlan; Mette M. Rosenkilde; Jonathan E. Campbell; Kyle W. Sloop

Jul 30, 2020JCI Insight

2020CrossrefSupporting evidence39 citations

Paediatric obesity treatment during 14 years in Sweden: Lessons from the Swedish Childhood Obesity Treatment Register—BORIS

Emilia Hagman; Pernilla Danielsson; Louise Lindberg; Claude Marcus

Jul 1, 2020Pediatric Obesity

2019OpenAlexDirectly related1,837 citations

Glucagon-like peptide 1 (GLP-1)

Timo D. Müller; Brian Finan; Stephen R. Bloom; David A. D’Alessio; Daniel J. Drucker; Peter R. Flatt; Andreas Fritsche; Fiona M. Gribble; Harvey J. Grill; Joel F. Habener; Jens J. Holst; Wolfgang Langhans; Juris J. Meier; Michael A. Nauck; Diego Pérez–Tilve; Alessandro Pocai; Frank Reimann; Darleen A. Sandoval; Thue W. Schwartz; Randy J. Seeley; Kerstin Stemmer; Mads Tang‐Christensen; Stephen C. Woods; Richard D. DiMarchi; M. Tschöp

Sep 30, 2019Molecular Metabolism